- Home
- SWK vs ASND Comparison
SWK vs ASND Comparison
Compare SWK & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWK
- ASND
- Stock Information
- Founded
- SWK 1843
- ASND 2006
- Country
- SWK United States
- ASND Denmark
- Employees
- SWK N/A
- ASND N/A
- Industry
- SWK Industrial Machinery/Components
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- SWK Consumer Discretionary
- ASND Health Care
- Exchange
- SWK Nasdaq
- ASND Nasdaq
- Market Cap
- SWK 11.1B
- ASND 10.6B
- IPO Year
- SWK N/A
- ASND 2015
- Fundamental
- Price
- SWK $77.56
- ASND $195.58
- Analyst Decision
- SWK Buy
- ASND Strong Buy
- Analyst Count
- SWK 10
- ASND 16
- Target Price
- SWK $93.33
- ASND $240.75
- AVG Volume (30 Days)
- SWK 2.1M
- ASND 413.2K
- Earning Date
- SWK 10-28-2025
- ASND 08-07-2025
- Dividend Yield
- SWK 4.28%
- ASND N/A
- EPS Growth
- SWK N/A
- ASND N/A
- EPS
- SWK 3.16
- ASND N/A
- Revenue
- SWK $15,161,600,000.00
- ASND $576,332,355.00
- Revenue This Year
- SWK $0.40
- ASND $101.37
- Revenue Next Year
- SWK $4.01
- ASND $76.17
- P/E Ratio
- SWK $24.55
- ASND N/A
- Revenue Growth
- SWK N/A
- ASND 54.50
- 52 Week Low
- SWK $53.91
- ASND $111.09
- 52 Week High
- SWK $110.88
- ASND $208.16
- Technical
- Relative Strength Index (RSI)
- SWK 56.88
- ASND 52.37
- Support Level
- SWK $76.06
- ASND $196.06
- Resistance Level
- SWK $80.06
- ASND $202.57
- Average True Range (ATR)
- SWK 2.02
- ASND 6.49
- MACD
- SWK 0.19
- ASND -0.82
- Stochastic Oscillator
- SWK 71.53
- ASND 34.34
About SWK Stanley Black & Decker Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates in two reportable segments namely Tools and Outdoor and Industrial. It generates maximum revenue from the Tools and Outdoor segment. The Tools and Outdoor segment is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) businesses. Geographically, the company generates revenue from the United States, Canada, Other Americas, Europe, and Asia. It derives a majority of its revenue from the United States.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.